🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the pharmacokinetics of dapivirine...
Status
Completed
Location
University of Pittsburgh CRS
Start Date
2018-05-10
Trial ID
NCT03393468
Treatments Being Tested
This study evaluate the pharmacokinetic and safety of IY-HCR21...
Status
Unknown
Location
H plus Yangji Hospital
Start Date
2024-06-10
Trial ID
NCT06471868
The purpose of this open label study in children and adolescents is to exam...
Status
Completed
Location
University of North Carolina, Department of Psychiatry
Start Date
2006-01
Trial ID
NCT00619190
Treatments Being Tested
The primary objective of this trial is to evaluate the efficacy of trastuzu...
Status
Terminated
Location
University of California San Diego (UCSD)
Start Date
2018-05-21
Trial ID
NCT03505710
Treatments Being Tested
This study evaluates the interest of regorafenib in combination of metronom...
Status
Recruiting
Location
CHU de Besançon
Start Date
2023-05-09
Trial ID
NCT05462613
The purpose of this research is to study the safety and effectiveness of in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12
Trial ID
NCT07783620
Treatments Being Tested
Myelodysplastic syndromes (MDS) are a group of bone marrow failures that oc...
Status
Recruiting
Location
Shaare Zedek Medical Center
Start Date
2024-05-27
Trial ID
NCT06465160
Treatments Being Tested
To date, very little is known about the mechanisms of open-label placebo tr...
Status
Completed
Location
University of Basel
Start Date
2016-01
Trial ID
NCT02578420
Treatments Being Tested
The purpose of this study is to assess the single dose pharmacokinetic prof...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01824524
Treatments Being Tested
\[F-18\]HX4 is being developed as a diagnostic radiopharmaceutical for PET ...
Status
Completed
Location
Michael Yu, MD
Start Date
2008-01
Trial ID
NCT00606424
Treatments Being Tested